CAH Stock: Cardinal Health, Inc. Stock Price, Analysis & Insights
Get live cah stock price $205.37, comprehensive Cardinal Health, Inc. stock analysis, charts, news, and expert forecast. Real-time cah stock data and investment insights.
Loading chart...
Company Overview
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Company Information
- CEO
- Jason M. Hollar
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 47922
Contact Information
- Address
- 7000 Cardinal Place
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 31.1)
✓ Lower volatility stock (Beta: 0.64) may provide portfolio stability
Business Model & Strategy
Cardinal Health, Inc. operates in the Medical - Distribution industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Jason M. Hollar, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Distribution model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Cardinal Health, Inc. competes in the Medical - Distribution within the broader Healthcare. With 48.8 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Cardinal Health, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Cardinal Health, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Cardinal Health, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Cardinal Health, Inc.
- ⚠Investors should consider how Cardinal Health, Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 31.1) requires strong growth to justify
Market Cap
48.80B
P/E Ratio
31.07
Beta
0.64
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 48.80B market capitalization
- Trading Volume: 2.52M shares traded today
- Price Range: 52-week range of $114.60 - $208.32
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Cardinal Health, Inc.
Cardinal Health, Inc. (CAH) operates in the Medical - Distribution industry within the Healthcare sector. With a current market capitalization of 48.80B, the company represents a significant player in its market. The stock is currently trading at $205.37 with a negativedaily change of 0.33%.
The company's 47922 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 31.07, beta of 0.64, and 52-week price range from $114.60 to $208.32when evaluating investment opportunities.
Why Invest in Cardinal Health, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Jason M. Hollar
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.